Wilm’s Disease (Renal Agenesis) – A Complete Medical Guide

Overview

Wilm’s disease is the historic name for **Wilms tumor**, a malignant kidney tumor that occurs most often in children. Because the word “renal agenesis” (absence of a kidney) is sometimes confused with Wilms tumor, this guide clarifies both conditions, outlines how they differ, and provides practical information for patients, families, and caregivers.

• Wilms tumor (Wilm’s disease) – a cancer arising from embryonic kidney tissue, typically diagnosed between ages 2‑5.
• Renal agenesis – a congenital condition in which one (unilateral) or both (bilateral) kidneys fail to develop.

Both conditions affect children, but the prevalence, causes, and management are distinct.

Key Statistics

• Wilms tumor accounts for ~6% of all childhood cancers, with an incidence of about 1 in 10,000 children worldwide (≈ 500 new cases per year in the United States) [1][2].
• Unilateral renal agenesis occurs in roughly 1 in 500–1,000 live births, while bilateral renal agenesis is far rarer (≈ 1 in 5,000–10,000) and usually fatal shortly after birth [3].
• Both conditions are slightly more common in females, but the gender difference is modest.

Symptoms

The clinical presentation varies markedly between Wilms tumor and renal agenesis.

Wilms Tumor (Wilm’s Disease)

• Abdominal mass – most common; a painless, firm, rubbery lump felt on one side of the abdomen.
• Abdominal pain – may occur if the tumor compresses surrounding structures.
• Hematuria – blood in the urine, seen in ~10% of cases.
• Hypertension – high blood pressure caused by renin secretion from the tumor.
• Fever or weight loss – less common, suggest more advanced disease.
• Respiratory symptoms – cough or shortness of breath if the tumor has spread to the lungs.

Renal Agenesis

• Unilateral agenesis (one kidney missing)
  • Often asymptomatic; discovered incidentally on imaging.
  • Possible flank discomfort or mild abdominal pain.
  • Occasional hypertension due to compensatory hyperfiltration.
• Bilateral agenesis (both kidneys missing)
  • Severe oligohydramnios (low amniotic fluid) detected on prenatal ultrasound.
  • Poor fetal growth, pulmonary hypoplasia, and often fetal demise or death shortly after birth.

Causes and Risk Factors

Wilms Tumor

Wilms tumor is primarily a sporadic disease, but several genetic and environmental factors increase risk.

• Genetic syndromes – e.g., WAGR syndrome (WT1 deletion), Beckwith‑Wiedemann syndrome, Denys‑Drash syndrome, and trisomy 18 [4].
• Family history – first‑degree relatives with Wilms tumor raise risk 2–3 fold.
• Premature birth – modestly higher incidence.
• Environmental exposures – parental smoking, certain chemotherapy agents, or radiation during early childhood have been implicated, though evidence is limited.

Renal Agenesis

• Genetic mutations – abnormalities in the RET, GDNF, or EYA1 pathways that guide kidney development.
• Maternal factors – diabetes, smoking, or medication use (e.g., ACE inhibitors) during the first trimester increase risk of unilateral agenesis [5].
• Chromosomal abnormalities – especially when renal agenesis is part of a broader syndrome such as Potter sequence.
• Family history – a sibling or parent with unilateral agenesis raises recurrence risk to ~2‑3%.

Diagnosis

Wilms Tumor

1. Physical examination – detection of an abdominal mass.
2. Imaging
   • Ultrasound – first‑line, characterizes solid vs cystic nature.
   • CT or MRI – defines tumor size, involvement of vessels, and metastatic spread, especially to lungs.
3. Laboratory tests
   • Complete blood count, serum chemistries, and urinalysis for hematuria.
   • Blood pressure measurement.
4. Biopsy – usually performed surgically (open or laparoscopic) at the time of nephrectomy; core needle biopsy is rare due to risk of tumor spill.
5. Staging – based on National Wilms Tumor Study (NWTS) criteria (Stage I‑V) which guide treatment intensity.

Renal Agenesis

1. Prenatal ultrasound – most common way to detect unilateral or bilateral agenesis during the second trimester.
2. Fetal MRI – clarifies anatomy, especially in complex cases.
3. Postnatal imaging
   • Renal ultrasound – confirms absence of kidney(s) and evaluates the contralateral kidney.
   • CT or MRI – reserved for surgical planning or when associated anomalies are suspected.
4. Genetic testing – targeted panels for WT1, RET, and other developmental genes if a syndrome is suspected.
5. Functional assessment – serum creatinine, eGFR, and blood pressure monitoring to evaluate the single kidney’s workload.

Treatment Options

Wilms Tumor

Treatment is multimodal and highly protocol‑driven, leading to >90% 5‑year survival for localized disease.

• Surgery – radical nephrectomy (removal of the affected kidney) is the cornerstone.
• Chemotherapy
  • Regimens commonly include vincristine, actinomycin‑D, and doxorubicin (for higher‑stage tumors).
  • Neoadjuvant (pre‑surgery) chemo may shrink a large tumor.
• Radiation therapy – indicated for Stage III/IV disease, incompletely resected tumors, or unfavorable histology.
• Targeted therapy/clinical trials – investigational agents (e.g., anti‑VEGF, mTOR inhibitors) are under study for refractory cases.

Renal Agenesis

• Unilateral agenesis – no specific “cure” is needed. Management focuses on preserving the function of the solitary kidney.
  • Regular monitoring of blood pressure, renal function, and proteinuria.
  • Avoiding nephrotoxic drugs (e.g., NSAIDs, certain antibiotics) whenever possible.
  • Early referral to a pediatric nephrologist.
• Bilateral agenesis – not compatible with life outside the womb; management is supportive and includes:
  • Prenatal counseling.
  • In cases of severe oligohydramnios, experimental fetal interventions (e.g., amnioinfusion) are occasionally attempted in specialized centers.

Living with Wilm’s Disease (Renal Agenesis)

For Children Treated for Wilms Tumor

• Follow‑up schedule – every 3‑6 months for the first 2 years, then annually. Includes physical exam, blood pressure, renal labs, and chest X‑ray.
• Nephroprotective lifestyle – maintain a balanced diet low in excess salt, stay hydrated, and limit exposure to toxins.
• Growth monitoring – chemotherapy may affect growth; coordinate care with a pediatric endocrinologist if needed.
• Psychosocial support – counseling, school accommodations, and peer support groups improve quality of life.

For Individuals with Unilateral Renal Agenesis

• Stay well‑hydrated (≥ 1.5 L/day unless otherwise advised).
• Avoid chronic use of NSAIDs, contrast dye, and high‑dose antibiotics unless required.
• Blood pressure checks at least annually; treat hypertension promptly.
• Annual urine dipstick for protein; persistent proteinuria warrants nephrology referral.
• Adopt a kidney‑friendly diet: moderate protein (0.8 g/kg), low‑sodium, and limited processed foods.
• Engage in regular moderate exercise (30 min most days) to support cardiovascular health.

Prevention

Because both conditions arise largely from developmental events beyond an individual’s control, primary prevention is limited. However, risk can be reduced through the following measures:

• Pre‑conception counseling for couples with a known familial kidney anomaly.
• Strict control of maternal diabetes and avoidance of smoking, alcohol, and nephrotoxic medications during early pregnancy.
• Genetic counseling for families with known WT1, RET, or other related mutations.
• Prompt treatment of maternal infections and careful medication review with obstetricians.
• For Wilms tumor, avoid unnecessary radiation exposure in early childhood; follow vaccination schedules to reduce infections that might trigger abnormal cell growth.

Complications

Wilms Tumor

• Recurrence (5‑10% depending on stage).
• Metastasis to lungs, liver, or brain.
• Long‑term renal insufficiency from loss of one kidney and chemotherapy toxicity.
• Cardiotoxicity from anthracyclines (doxorubicin) – may lead to reduced ejection fraction.
• Secondary malignancies (e.g., leukemia) after radiation or certain chemotherapies.

Renal Agenesis

• Hypertension due to hyperfiltration injury in the solitary kidney.
• Progressive chronic kidney disease (CKD) over decades.
• Increased susceptibility to urinary tract infections.
• Pregnancy‑related complications in women with a single kidney (higher risk of preeclampsia, preterm delivery).

When to Seek Emergency Care

---

References

1. American Cancer Society. “Wilms Tumor.” 2023. https://www.cancer.org/cancer/wilms-tumor.html
2. National Cancer Institute. “Wilms Tumor Treatment (PDQ®)–Patient Version.” 2022. https://www.cancer.gov/types/kidney/patient/wilms-treatment-pdq
3. National Institute of Diabetes and Digestive and Kidney Diseases. “Renal Agenesis.” 2021. https://www.niddk.nih.gov/health-information/kidney-disease/renal-agenesis
4. Stolar, Z., et al. “Genetic Basis of Wilms Tumor.” *Pediatr Blood Cancer*, 2020. DOI:10.1002/pbc.28456
5. Centers for Disease Control and Prevention. “Maternal Risk Factors for Congenital Anomalies.” 2022. https://www.cdc.gov/ncbddd/birthdefects/maternalrisk.html
6. Mayo Clinic. “Wilms Tumor (Kidney Cancer) – Symptoms and Causes.” 2024. https://www.mayoclinic.org/diseases-conditions/wilms-tumor/symptoms-causes/syc-20375664